Enteric fever, encompassing typhoid and paratyphoid fever, remains a significant global health issue. Despite advances in diagnostics and therapeutics, the disease continues to pose challenges due to its non-specific clinical presentation and the emergence of multi-drug resistant strains. This article aims to provide an updated approach to the diagnosis and management of enteric fever.
Early diagnosis of enteric fever is crucial to improving patient outcomes and preventing disease spread. Traditional culture methods, though considered gold standard, are time-consuming and lack sensitivity. Recent advancements in molecular diagnostics, such as polymerase chain reaction (PCR) assays, offer faster and more accurate detection of Salmonella Typhi and Paratyphi. However, their application in clinical practice is limited by cost and availability in resource-limited settings.
Antimicrobial therapy remains the mainstay of enteric fever management. The choice of antimicrobial should be guided by local resistance patterns. Fluoroquinolones, once the treatment of choice, are now less frequently used due to widespread resistance. Instead, third-generation cephalosporins and azithromycin have emerged as preferred options. The emergence of extensively drug-resistant (XDR) strains necessitates the use of newer agents like carbapenems and tigecycline.
Vaccination plays a crucial role in the control of enteric fever, especially in endemic regions. Two vaccines, Vi polysaccharide vaccine and Ty21a, are currently available and recommended for high-risk populations and travelers to endemic areas. Additionally, safe water and food practices, improved sanitation, and public health surveillance are pivotal in preventing the spread of enteric fever.
In conclusion, the management of enteric fever requires a multifaceted approach, encompassing rapid and accurate diagnostics, appropriate antimicrobial therapy guided by local resistance patterns, and preventive strategies including vaccination and improved sanitation. Keeping abreast with the latest developments in these areas is essential for clinicians involved in the care of patients with enteric fever.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation